Non-neurological, steroid-related adverse events in very low birth weight infants: a prospective audit

To assess the incidence of cardiac and metabolic adverse events in very low birth weight (VLBW) infants receiving systematic steroids. Prospective single centre audit in VLBW infants (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Swiss medical weekly 2014-04, Vol.144 (1314), p.w13954-w13954
Hauptverfasser:	Röhr, S B, Sauer, H, Gottschling, S, Abdul-Khaliq, H, Gortner, L, Nunold, H, Gräber, S, Meyer, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - adverse effects Apgar Score Birth Weight Cardiomyopathy, Hypertrophic - chemically induced Dexamethasone - adverse effects Female Gestational Age Humans Hydrocortisone - adverse effects Hyperglycemia - chemically induced Hypernatremia - chemically induced Infant, Newborn Infant, Very Low Birth Weight Male Postnatal steroids - Hydrocortisone - Dexamethasone - VLBW infant - Hypertrophic cardiomyopathy - Thrombus Prospective Studies Respiratory Distress Syndrome, Newborn - drug therapy Respiratory Insufficiency - drug therapy Sepsis - chemically induced Severity of Illness Index Thrombosis - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To assess the incidence of cardiac and metabolic adverse events in very low birth weight (VLBW) infants receiving systematic steroids. Prospective single centre audit in VLBW infants (
ISSN:	1424-7860 1424-3997
DOI:	10.4414/smw.2014.13954